Articles

• Select this article
  • K V Desai,
  • C J Kavanaugh,
  • A Calvo,
  • and J E Green

  Chipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer.

  Endocr Relat Cancer 9 (4) 207-20, doi:10.1677/erc.0.0090207
  • Abstract
  • Full Text (PDF)
• Select this article
  • K Hussain,
  • K E Cosgrove,
  • R M Shepherd,
  • J C Chapman,
  • S M Swift,
  • V V Smith,
  • S A Kassem,
  • B Glaser,
  • K J Lindley,
  • A Aynsley-Green,
  • and M J Dunne

  Uncontrolled insulin secretion from a childhood pancreatic beta-cell adenoma is not due to the functional loss of ATP-sensitive potassium channels.

  Endocr Relat Cancer 9 (4) 221-6, doi:10.1677/erc.0.0090221
  • Abstract
  • Full Text (PDF)
• Select this article
  • E L Mazzaferri and
  • N Massoll

  Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.

  Endocr Relat Cancer 9 (4) 227-47, doi:10.1677/erc.0.0090227
  • Abstract
  • Full Text (PDF)
• Select this article
  • M Cristofanilli and
  • G N Hortobagyi

  Molecular targets in breast cancer: current status and future directions.

  Endocr Relat Cancer 9 (4) 249-66, doi:10.1677/erc.0.0090249
  • Abstract
  • Full Text (PDF)
• Select this article
  • C Morris and
  • A Wakeling

  Fulvestrant ('Faslodex')--a new treatment option for patients progressing on prior endocrine therapy.

  Endocr Relat Cancer 9 (4) 267-76, doi:10.1677/erc.0.0090267
  • Abstract
  • Full Text (PDF)